Sunday, 03, May, 2026
 
 
 
Expand O P Jindal Global University
 
  
  
 
 
 

Comet Healthcare And Consulting ... vs ...
2015 Latest Caselaw 4169 Del

Citation : 2015 Latest Caselaw 4169 Del
Judgement Date : 25 May, 2015

Delhi High Court
Comet Healthcare And Consulting ... vs ... on 25 May, 2015
Author: Sudershan Kumar Misra
                    IN THE HIGH COURT OF DELHI
              COMPANY APPLICATION (MAIN) NO. 73/2015

                                            Reserved on 21st May, 2015
                                Date of pronouncement: 25th May, 2015
In the matter of
The Companies Act, 1956 & the Companies Act, 2013 (to the extent
applicable):

And

Application under Sections 391 & 394 of the
Companies Act, 1956 read with Rule 9 of the
Companies (Court) Rules, 1959

Scheme of Amalgamation of:

Comet Healthcare and Consulting Private Limited
                                  Applicant/Transferor Company No. 1
RG Medicity Private Limited
                                     Applicant/Transferor Company No. 2
R.B. Medicare Limited
                                     Applicant/Transferor Company No. 3
       WITH
R.G. Scientific Enterprises Private Limited
                                              Applicant/Transferee Company

                                Through Mr. Kunal Juneja and
                                Mr.Karan Mehra, Advocates for the
                                applicants

SUDERSHAN KUMAR MISRA, J.

1. This joint application has been filed under Sections 391 & 394 of

the Companies Act, 1956 read with Rule 9 of the Companies (Court)

rules, 1959 by the applicant companies seeking directions of this court to

dispense with the requirement of convening the meetings of their equity

shareholders, secured and unsecured creditors to consider and approve,

with or without modification, the proposed Scheme of Amalgamation of

Comet Healthcare and Consulting Private Limited (hereinafter referred to

as the transferor company no. 1); RG Medicity Private Limited

(hereinafter referred to as the transferor company no. 2); and R.B.

Medicare Limited (hereinafter referred to as the transferor company no.3)

with R.G. Scientific Enterprises Private Limited (hereinafter referred to as

the transferee company).

2. The registered offices of the transferor and transferee companies

are situated at New Delhi, within the jurisdiction of this Court.

3. The transferor company no. 1 was originally incorporated under the

Companies Act, 1956 on 7th December, 2010 with the Registrar of

Companies, NCT of Delhi & Haryana at New Delhi under the name and

style of Comet Education Services Private Limited. The company

changed its name to Comet Healthcare & Consulting Private Limited and

obtained the fresh certificate of incorporation on 7th December, 2010.

4. The transferor company no. 2 was incorporated under the

Companies Act, 1956 on 28th January, 2005 with the Registrar of

Companies, NCT of Delhi & Haryana at New Delhi.

5. The transferor company no. 3 was incorporated under the

Companies Act, 1956 on 25th August, 1993 with the Registrar of

Companies, NCT of Delhi & Haryana at New Delhi.

6. The transferee company was originally incorporated under the

Companies Act, 1956 on 28th February, 1986 with the Registrar of

Companies, NCT of Delhi & Haryana at New Delhi under the name and

style of R.G. Scientific Enterprises Private Limited. The company

changed its name to R.G. Scientific Enterprises Limited and obtained a

fresh certificate of incorporation on 24th September, 2007. The company

again changed its name to R.G. Scientific Enterprises Private Limited

and obtained the fresh certificate of incorporation on 17th February, 2011.

7. The present authorized share capital of the transferor company

no.1 is Rs.12,50,00,000/- divided into 1,25,00,000 equity shares of

Rs.10/- each. The issued, subscribed and paid-up share capital of the

company is Rs.12,07,66,670/- divided into 1,20,76,667 equity shares of

Rs.10/- each.

8. The present authorized share capital of the transferor company

no.2, is Rs.10,00,000/- divided into 1,00,00 equity shares of Rs.10/-

each. The issued, subscribed and paid-up share capital of the company

is Rs.1,00,000/- divided into 10,000 equity shares of Rs.100/- each.

9. The present authorized share capital of the transferor company

no.3 is Rs.3,00,00,000/- divided into 30,00,000 equity shares of Rs.10/-

each. The issued, subscribed and paid-up share capital of the company

is Rs.1,18,34,000/- divided into 11,83,400 equity shares of Rs.10/- each.

10. The present authorized share capital of the transferee company is

Rs.5,00,00,000/- divided into 5,00,000 equity shares of Rs.100/- each.

The present issued, subscribed and paid-up share capital of the

company is Rs.2,34,10,600/- divided into 2,34,106 equity shares of

Rs.100/- each.

11. Copies of the Memorandum and Articles of Association of the

transferor and transferee companies have been filed on record. The

audited balance sheets, as on 31st March, 2014, of the transferor and

transferee companies, along with the report of the auditors, have also

been filed.

12. A copy of the Scheme of Amalgamation has been placed on record

and the salient features of the Scheme have been incorporated and

detailed in the application and the accompanying affidavits. It is

submitted by the applicants that the objective of the Scheme is to enable

appropriate consolidation of activities of the transferor companies and the

transferee company with pooling and more effective utilization of their

resources, reduction in overhead and other expenses, improvement in

various operating parameters and synergy benefits which will help to

streamline the corporate structure of the group.

13. So far as the share exchange ratio is concerned, the Scheme

provides that, upon coming into effect of this Scheme, the transferee

company shall issue and allot equity shares to the shareholders of the

transferor companies in the following ratio:-

"49 equity shares of Rs.100/- each of the transferee company for every 6336 equity shares of Rs.10/- each held in the transferor company no. 1."

"01 equity share of Rs.100/- each of the transferee company for every 1000 equity shares of Rs.10/- each held in the transferor company no. 2."

"01 equity share of Rs.100/- each of the transferee company for every 1000 equity shares of Rs.10/- each held in the transferor company no. 3."

14. It has been submitted by the applicants that no proceedings under

Sections 235 to 251 of the Companies Act, 1956 are pending against the

applicant companies.

15. The Board of Directors of the transferor and transferee companies

in their separate meetings held on 10th November, 2014 have

unanimously approved the proposed Scheme of Amalgamation. Copies

of the Resolutions passed at the meetings of the Board of Directors of

the transferor and transferee companies have been placed on record.

16. The transferor company no. 1 has 02 equity shareholders and 02

unsecured creditors. Both the equity shareholders and both the

unsecured creditors have given their consents/no objections in writing to

the proposed Scheme of Amalgamation. Their consents/no objections

have been placed on record. They have been examined and found in

order. In view thereof, the requirement of convening the meetings of the

equity shareholders and unsecured creditors of the transferor company

no. 1 to consider and, if thought fit, approve, with or without modification,

the proposed Scheme of Amalgamation is dispensed with. There is no

secured creditor of the transferor company no. 1, as on 3rd March, 2015.

17. The transferor company no. 2 has 02 equity shareholders and 01

unsecured creditor. Both the equity shareholders and the only unsecured

creditor have given their consents/no objections in writing to the

proposed Scheme of Amalgamation. Their consents/no objections have

been placed on record. They have been examined and found in order. In

view thereof, the requirement of convening the meetings of the equity

shareholders and unsecured creditor of the transferor company no. 2 to

consider and, if thought fit, approve, with or without modification, the

proposed Scheme of Amalgamation is dispensed with. There is no

secured creditor of the transferor company no. 2, as on 31st March, 2014.

18. The transferor company no. 3 has 09 equity shareholders. All the

equity shareholders have given their consents/no objections in writing to

the proposed Scheme of Amalgamation. Their consents/no objections

have been placed on record. They have been examined and found in

order. In view thereof, the requirement of convening the meeting of the

equity shareholders of the transferor company no. 3 to consider and, if

thought fit, approve, with or without modification, the proposed Scheme

of Amalgamation is dispensed with. There is no secured or unsecured

creditor of the transferor company no. 3.

19. The transferee company has 06 equity shareholders. Learned

counsel for the applicants has submitted that transferor company no. 1 is

one of the shareholders of the transferee company, and its consent is not

required since the company is itself a part of the Scheme. The remaining

05 equity shareholders have given their consents/no objection in writing

to the proposed Scheme of Amalgamation. Their consents/no objections

have been placed on record. They have been examined and found in

order. In view thereof, the requirement of convening the meeting of the

equity shareholders of the transferee company to consider and, if thought

fit, approve, with or without modification, the proposed Scheme of

Amalgamation is dispensed with.

20. The transferee company has 07 secured creditors. Learned

counsel for the applicants has submitted that the loan of two secured

creditors namely HDFC Bank and Kotak Mahindra Bank Limited have

been paid off in full and the loan closure letter from the HDFC Bank and a

certificate of the Chartered Accounting certifying that the loan of Kotak

Mahindra Bank Limited has been paid off in full has been placed on

record. The remaining 05 secured creditors have given their consents/no

objection in writing to the proposed Scheme of Amalgamation. Their

consents/no objections have been placed on record. They have been

examined and found in order. In view thereof, the requirement of

convening the meeting of the secured creditors of the transferee

company to consider and, if thought fit, approve, with or without

modification, the proposed Scheme of Amalgamation is dispensed with.

21. The transferee company has 04 unsecured creditors. Learned

counsel for the applicants has submitted that transferor company no. 1 is

one of the unsecured creditors of the transferee company representing

4.29% of the total unsecured debt, and its consent is not required since

the company is itself a part of the Scheme. 02 out of the remaining 03

unsecured creditors representing 77.20% in value of the total unsecured

debt have given their consents/no objection in writing to the proposed

Scheme of Amalgamation. Their consents/no objections have been

placed on record. They have been examined and found in order. In view

thereof, the requirement of convening the meeting of the unsecured

creditors of the transferee company to consider and, if thought fit,

approve, with or without modification, the proposed Scheme of

Amalgamation is dispensed with.

22. The application stands allowed in the aforesaid terms.

Dasti

SUDERSHAN KUMAR MISRA, J.

May 25, 2015

 
Download the LatestLaws.com Mobile App
 
 
Latestlaws Newsletter
 

Publish Your Article

 

Campus Ambassador

 

Media Partner

 

Campus Buzz

 

LatestLaws Guest Court Correspondent

LatestLaws Guest Court Correspondent Apply Now!
 

LatestLaws.com presents: Lexidem Offline Internship Program, 2026

 

LatestLaws.com presents 'Lexidem Online Internship, 2026', Apply Now!

 
 

LatestLaws Partner Event : Smt. Nirmala Devi Bam Memorial International Moot Court Competition

 
 
Latestlaws Newsletter